LIFE - CIK 0001339970
The table below shows aTYR PHARMA INC's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $10.74M | $11.05M | $22.54M | $9.98M | $2.34M | $16.95M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $80.24M |
| $81.95M |
| $102.99M |
| $80.87M |
| $113.57M |
| $35.53M |
| Property, plant & equipment | $4.26M | $4.85M | $5.53M | $3.06M | $543.00K | $899.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $93.00M | $96.83M | $120.65M | $95.79M | $115.54M | $38.73M |
| Accounts payable | $3.89M | $4.32M | $3.53M | $3.11M | $1.03M | $1.43M |
| Total current liabilities | $15.15M | $14.97M | $16.42M | $13.86M | $6.01M | $5.86M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | - | - | - | - | - | - |
| Retained earnings | -$606.16M | -$532.05M | -$468.02M | -$417.63M | -$372.30M | -$338.53M |
| Total equity | $67.48M | $70.02M | $90.66M | $71.46M | $109.30M | $31.65M |